Dendritic cell based therapy of cancer.
Lotze
M T
MT
Department of Surgery, University of Pittsburgh School of Medicine, Pennsylvania 15261, USA.
Shurin
M
M
Davis
I
I
Amoscato
A
A
Storkus
W J
WJ
D000818:Animals; D000951:Antigens, Neoplasm / Q000008:administration & dosage / Q000235:genetics; D019496:Cancer Vaccines / Q000008:administration & dosage; D002450:Cell Communication; D002465:Cell Movement; D016207:Cytokines / Q000096:biosynthesis; D004273:DNA, Neoplasm / Q000008:administration & dosage / Q000235:genetics; D003713:Dendritic Cells / Q000276:immunology* / Q000473:pathology; D005818:Genetic Engineering; D006360:Heat-Shock Proteins / Q000008:administration & dosage; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D051379:Mice; D009369:Neoplasms / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D010455:Peptides / Q000008:administration & dosage / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology
D000951:Antigens, Neoplasm; D019496:Cancer Vaccines; D016207:Cytokines; D004273:DNA, Neoplasm; D006360:Heat-Shock Proteins; D010455:Peptides